NFA-17146-60218
4 vaccinations
1 coded response
47 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 958 / CA
- Registered
- 2021-03-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-07
Registered in v-safe
-
2021-03-07
Dose 1 — Pfizer-BioNTech
- 2021-03-07
-
2021-03-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-03-09
-
2021-03-10
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-23
-
2021-03-28
Dose 2 — Pfizer-BioNTech
- 2021-03-28
- 2021-03-29
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Muscle or body achesAdult check-in
- 2021-04-04
- 2021-04-11
- 2021-04-19
- 2021-04-25
- 2021-05-02
- 2021-05-09
- 2021-06-27
- 2021-09-28
-
2021-11-15
Dose 3 — Moderna
- 2021-11-15
-
2021-11-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-11-17
- 2021-11-18
- 2021-11-19
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-21
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-13
- 2021-12-20
- 2021-12-27
- 2022-02-14
- 2022-05-18
-
2022-09-14
Dose 4 — Moderna
-
2022-09-17
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-18
- 2022-09-19
- 2022-09-20
- 2022-09-21
- 2022-09-28
- 2022-10-07
- 2022-10-14
- 2022-10-19
- 2022-10-26
- 2022-12-14
-
2023-03-15
Survey response — 6 months, dose 4MedDRA: Pre-eclampsia, Premature separation of placenta — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationMedDRA releases: 2024-11
-
2023-03-15
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2023-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Pfizer-BioNTech | |
| 2 | 2021-03-28 | Pfizer-BioNTech | |
| 3 | 2021-11-15 | Moderna | No |
| 4 | 2022-09-14 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Premature separation of placenta | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release